drugset / Trial / NCT00654498
Pramipexole in Out-patients With Idiopathic Restless Legs Syndrome (IRLS)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To determine efficacy and safety of Pramipexole 0.125mg to 0.75mg daily for 6 weeks compared to placebo in the treatment of idiopathic Restless Legs Syndrome (RLS)
Timeline
- Start
- 2008-04
- Primary completion
- 2009-06
- Completion
- 2009-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pramipexole | Unknown | 0.125 mg | Oral |
| Subject | Pramipexole | Unknown | 0.25 mg | Oral |
| Subject | Pramipexole | Unknown | 0.5 mg | Oral |
| Subject | Pramipexole | Unknown | 0.75 mg | Oral |